Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

This study has been terminated.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: October 5, 2007
Last updated: June 11, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2003
  Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)